Mutational Analysis of Fukutin Gene in Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy

被引:15
|
作者
Arimura, Takuro
Hayashi, Yukiko K. [2 ]
Murakami, Terumi [2 ]
Oya, Yasushi [3 ]
Funabe, Sayaka
Arikawa-Hirasawa, Eri
Hattori, Nobutaka
Nishino, Ichizo [2 ]
Kimura, Akinori [1 ,4 ]
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Bunkyo Ku, Tokyo 1138510, Japan
[2] Juntendo Univ, Sch Med, Dept Neuromuscular Res, Natl Inst Neurosci,NCNP, Tokyo 113, Japan
[3] Juntendo Univ, Sch Med, Dept Neurol, Natl Ctr Hosp Neurol & Psychiat,NCNP, Tokyo 113, Japan
[4] Tokyo Med & Dent Univ, Sch Biomed Sci, Lab Genome Divers, Tokyo 1138510, Japan
基金
日本学术振兴会;
关键词
Cardiomyopathy; Genes; Genetics; Muscles; CONGENITAL MUSCULAR-DYSTROPHY; FUKUYAMA-TYPE; RETROTRANSPOSAL INSERTION; JAPANESE; TITIN; PATIENT; FCMD;
D O I
10.1253/circj.CJ-08-0722
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Mutations in FKTN encoding for fukutin cause Fukuyama-type congenital muscular dystrophy characterized by severe muscle wasting and hypotonia with mental retardation. Fukuyama-type congenital muscular dystrophy is a recessive genetic trait. FKTN mutations in patients with dilated cardiomyopathy (DCM) have been investigated by our research group. The patients showed hyper-CKemia with mild or no muscle weakness and without mental retardation, suggesting that the clinical spectrum of FKTN mutations are wider than previously thought. The current study was designed to further explore the association of FKTN mutations with DCM or hypertrophic cardiomyopathy (HCM). Methods and Results A total of 172 patients with DCM, 144 patients with familial HCM and 384 control individuals were analyzed for FKTN mutations. There was a DCM patient who was a compound heterozygote of a 3-kb insertion mutation and a missense mutation Cys 101 Phe. The patient showed hyper-CKemia with mild muscle involvement and no brain involvement. In contrast, 2 other DCM patients and 3 controls were heterozygous for the insertion mutation and normal allele, showing that the heterozygous insertion mutation itself was not associated with DCM. No Mutation was found in the HCM patients. Conclusions These observations indicated that the compound heterozygous FKTN mutation was a rare cause of DCM. Hyper-CKemia might be indicative of FKTN mutation in DCM. (Circ J 2009; 73: 158 - 161)
引用
收藏
页码:158 / 161
页数:4
相关论文
共 50 条
  • [31] Detection and Diagnosis of Dilated and Hypertrophic Cardiomyopathy by Echocardiogram Sequences Analysis
    Balaji, G. N.
    Subashini, T. S.
    Chidambaram, N.
    Balasubramaiyan, E.
    COMPUTATIONAL INTELLIGENCE, CYBER SECURITY AND COMPUTATIONAL MODELS, ICC3 2015, 2016, 412 : 289 - 300
  • [32] Comparison of repolarization abnormality during exercise in dilated cardiomyopathy and hypertrophic cardiomyopathy
    Kuroda, N
    Ohnishi, Y
    Yamashiro, K
    Okajima, K
    Ishida, A
    Javier, GE
    Yokoyama, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 114A - 114A
  • [33] Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
    Puckelwartz, Megan J.
    Pesce, Lorenzo L.
    Dellefave-Castillo, Lisa M.
    Wheeler, Matthew T.
    Pottinger, Tess D.
    Robinson, Avery C.
    Kearns, Samuel D.
    Gacita, Anthony M.
    Schoppen, Zachary J.
    Pan, Wenyu
    Kim, Gene
    Wilcox, Jane E.
    Anderson, Allen S.
    Ashley, Euan A.
    Day, Sharlene M.
    Cappola, Thomas
    Dorn, Gerald W.
    McNally, Elizabeth M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (07):
  • [34] Progression of hypertrophic cardiomyopathy to dilated cardiomyopathy - A case reports and review of the literatures
    Chang, KH
    Ha, JW
    Chung, NS
    Cho, SY
    YONSEI MEDICAL JOURNAL, 1998, 39 (01) : 61 - 66
  • [35] HOMOZYGOUS FUKUTIN MISSENSE MUTATION IN TWO MEXICAN SIBLINGS WITH DILATED CARDIOMYOPATHY
    Villarreal-Molina, Maria T.
    Rosas-Madrigal, Sandra
    Lopez-Mora, Enrique
    Calderon-Avila, Ana L.
    Rodriguez-Zanella, Hugo
    Romero-Hidalgo, Sandra
    Rosendo-Gutierrez, Rigoberto
    Carnevale, Alessandra
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (03): : 132 - 137
  • [36] Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy
    Nanni, L
    Pieroni, M
    Chimenti, C
    Simionati, B
    Zimbello, R
    Maseri, A
    Frustaci, A
    Lanfranchi, G
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 309 (02) : 391 - 398
  • [37] Hypertrophic cardiomyopathy: two homozygous cases with "typical hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy
    Nanni, L
    Chimenti, C
    Pieroni, M
    Simionati, B
    Zimbello, R
    Lanfranchi, G
    Maseri, A
    Frustaci, A
    EUROPEAN HEART JOURNAL, 2003, 24 : 555 - 555
  • [38] Primary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy
    Klein, GJ
    Krahn, AD
    Skanes, AC
    Yee, R
    Gula, LJ
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (09) : S28 - S34
  • [39] Sympathetic overactivation in dilated phase of hypertrophic cardiomyopathy
    Ushijima, R.
    Joho, S.
    Oda, Y.
    Harada, D.
    Hirai, T.
    Asanoi, H.
    Inoue, H.
    EUROPEAN HEART JOURNAL, 2011, 32 : 914 - 914
  • [40] Common pathways for primary hypertrophic and dilated cardiomyopathy
    Kroumpouzou, E
    Gomatos, IP
    Kataki, A
    Karayannis, M
    Dangas, GD
    Toutouzas, P
    HYBRIDOMA AND HYBRIDOMICS, 2003, 22 (01): : 41 - 45